The Ion Torrent Oncomine Myeloid Research Assay is a comprehensive, targeted NGS assay designed to assist in the understanding of myeloid cancer. Specifically, it interrogates relevant DNA mutations and fusion transcripts associated with myeloid disorders in a quick and easy NGS run. Our panel is comprised of 40 key DNA target genes and 29 driver genes in a broad fusion panel to cover all the major myeloid disorders: acute myeloid leukemia (AML), myeloid dysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), chronic myeloid leukemia (CML), chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).
Key product attributes
From nucleic acid sample to report in <48 hours
Total hands-on-time using automation is typically <30 minutes
Comprehensive coverage—40 key DNA genes and 29 RNA fusion transcript driver genes
Fully annotated variants in Ion Torrent Oncomine Reporter that links to relevant labels, guidelines, and global clinical trials
Targeted content strategy
The content of our panel was carefully selected by our dedicated team of manual curators together with extensive consultation with global experts and international guidelines.